Your browser doesn't support javascript.
loading
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Lin, Genevieve Ihsiu; Makrakis, Dimitrios; Diamantopoulos, Leonidas N; Tripathi, Nishita; Agarwal, Neeraj; Zakopoulou, Roubini; Bamias, Aristotelis; Brown, Jason R; Pinato, David J; Korolewicz, James; Jindal, Tanya; Koshkin, Vadim S; Murgic, Jure; Miletic, Marija; Frobe, Ana; Johnson, Jeffrey; Zakharia, Yousef; Drakaki, Alexandra; Rodriguez-Vida, Alejo; Rey-Cárdenas, Macarena; Castellano, Daniel; Buznego, Lucia Alonso; Duran, Ignacio; Carballeira, Clara Castro; Barrera, Rafael Morales; Marmorejo, David; McKay, Rana R; Stewart, Tyler; Gupta, Shilpa; Ruplin, Andrew Thomas; Yu, Evan Y; Khaki, Ali R; Grivas, Petros.
Afiliación
  • Bakaloudi DR; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Talukder R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Lin GI; Department of Epidemiology, University of Washington, Seattle, WA.
  • Makrakis D; Department of Medicine, Jacobi Medical Center-Albert Einstein College of Medicine, Bronx, NY.
  • Diamantopoulos LN; Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Tripathi N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT.
  • Agarwal N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT.
  • Zakopoulou R; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Bamias A; 2nd Propaedeutic Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Brown JR; Division of Oncology, University Hospitals Seidman Cancer Center, Clevelant, OH.
  • Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, UK; Division of Oncology, Department of Translational Medicine (DIMET), University of Piemonte Orientale, Novara, Italy.
  • Korolewicz J; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, UK.
  • Jindal T; Division of Hematology/Oncology, Department of Medicine, Helen Diller Family Cancer Center, University of California San Francisco, San Francisco, CA.
  • Koshkin VS; Division of Hematology/Oncology, Department of Medicine, Helen Diller Family Cancer Center, University of California San Francisco, San Francisco, CA.
  • Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, School of Dental Medicine, Zagreb, Croatia.
  • Miletic M; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, School of Dental Medicine, Zagreb, Croatia.
  • Frobe A; Department of Oncology and Nuclear Medicine, Faculty of Dentistry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
  • Johnson J; Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA.
  • Zakharia Y; Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA.
  • Drakaki A; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
  • Rodriguez-Vida A; Medical Oncology Department, Hospital del Mar, IMM Research Institute, Barcelona, Spain.
  • Rey-Cárdenas M; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Buznego LA; Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain.
  • Duran I; Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain.
  • Carballeira CC; Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain.
  • Barrera RM; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Marmorejo D; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA.
  • Stewart T; Moores Cancer Center, University of California San Diego, La Jolla, CA.
  • Gupta S; Department of Hematology and Oncology, Taussig cancer Institute, Cleveland Clinic Foundation, Cleveland, OH.
  • Ruplin AT; Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA.
  • Yu EY; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Khaki AR; Division of Oncology, Department of Medicine, Stanford University, Palo Alto, CA. Electronic address: alikhaki@stanford.edu.
  • Grivas P; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA. Electronic address: pgrivas@uw.edu.
Clin Genitourin Cancer ; 21(5): 584-593, 2023 10.
Article en En | MEDLINE | ID: mdl-37414620
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Genitourin Cancer Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2023 Tipo del documento: Article